ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

YS YS Biopharma Company Ltd

0.75
0.046 (6.53%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 40,645
Bid Price 0.70
Ask Price 0.89
News -
Day High 0.7667

Low
0.3503

52 Week Range

High
1.94

Day Low 0.711
Company Name Stock Ticker Symbol Market Type
YS Biopharma Company Ltd YS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.046 6.53% 0.75 18:07:51
Open Price Low Price High Price Close Price Prev Close
0.72 0.711 0.7667 0.75 0.704
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
97 40,645 $ 0.7415325 $ 30,140 - 0.3503 - 1.94
Last Trade Time Type Quantity Stock Price Currency
18:12:08 13 $ 0.74 USD

YS Biopharma Company Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.44M 93.06M - 687.2M -283.47M -3.05 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

YS Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No YS Message Board. Create One! See More Posts on YS Message Board See More Message Board Posts

Historical YS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.82290.850.7040.771207552,850-0.0729-8.86%
1 Month0.751.02850.700.8468399167,6390.000.00%
3 Months0.401.02850.36070.6360156193,2810.3587.50%
6 Months0.4761.02850.35030.5674316161,2840.27457.56%
1 Year1.891.940.35031.19494,865-1.14-60.32%
3 Years12.6712.930.35031.39577,552-11.92-94.08%
5 Years12.6712.930.35031.39577,552-11.92-94.08%

YS Biopharma Description

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China.

Your Recent History

Delayed Upgrade Clock